- Research works
- 26 ▲ 32% vs 2013–17
- Citations
- 1.7k 65.6 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 33% world 28%
Not ranked overall: Médical Innovation Développement (France) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Neuroscience, 5.4×. Every wedge is a field page.
Which keywords describe research at Médical Innovation Développement (France)?
By fractional works in all years, weighted toward what it does more of than the world: Foxp3, TGF-ß, Cancer Immunotherapy, Immunity, Antigen Presentation, Dendritic Cells, Natural Killer Cells and NK Cell Recognition.
- Fc Receptors
- Renal Allograft
- Immunosuppressive Drugs
- Natural Killer Cells
- Dendritic Cells
- Immunity
- TGF-ß
- Foxp3
- Cancer Immunotherapy
- Antigen Presentation
- NK Cell Recognition
- Graft Survival
- Kidney Transplantation
- Inflammation
- Therapeutic Antibodies
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 15 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 15 words, with their numbers
- Foxp32▲ 132×1 topic
- TGF-ß2▲ 57×1 topic
- Cancer Immunotherapy2▲ 62×3 topics
- Immunity2▲ 25×2 topics
- Antigen Presentation2▲ 82×1 topic
- Dendritic Cells2▲ 71×1 topic
- NK Cell Recognition2▲ 80×1 topic
- Natural Killer Cells2▲ 80×1 topic
- Graft Survival2▲ 75×2 topics
- Immunosuppressive Drugs2▲ 121×2 topics
- Kidney Transplantation2▲ 93×1 topic
- Renal Allograft2▲ 156×1 topic
- Inflammation2▲ 2.5×7 topics
- Fc Receptors1▲ 50×1 topic
- Therapeutic Antibodies1▲ 39×1 topic
Which research topics does Médical Innovation Développement (France) publish most on?
By volume in 2022–2025: Air Quality and Health Impacts, Vehicle emissions and performance, Pharmacological Effects and Toxicity Studies and Water Systems and Optimization.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Air Quality and Health Impacts Health, Toxicology and Mutagenesis 0 works
- 2 Vehicle emissions and performance Automotive Engineering 0 works
- 3 Pharmacological Effects and Toxicity Studies Pediatrics, Perinatology and Child Health 0 works
- 4 Water Systems and Optimization Civil and Structural Engineering 0 works
- 5 Infrastructure Maintenance and Monitoring Civil and Structural Engineering 0 works
- 6 Structural Health Monitoring Techniques Civil and Structural Engineering 0 works
- 7 Atmospheric chemistry and aerosols Atmospheric Science 0 works
- 8 Vehicle Dynamics and Control Systems Automotive Engineering 0 works
- 9 Health, Medicine and Society General Health Professions 0 works
- 10 Palliative Care and End-of-Life Issues Public Health, Environmental and Occupational Health 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Médical Innovation Développement (France)'s research output changed?
Output in 2018–2022 was 32% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Dardilly
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.